Sana Biotechnology (SANA) Other Gross PP&E Adjustments (2020 - 2026)

Sana Biotechnology recorded quarterly Other Gross PP&E Adjustments of $44.5 million in Q1 2026, up 6.95% quarter-over-quarter from $41.6 million in Q4 2025, and down 40.51% year-over-year from $74.9 million in Q1 2025.

Sana Biotechnology's Other Gross PP&E Adjustments history runs 7 years deep, the most recent figure standing at $44.5 million for Q1 2026.

  • In Q1 2026, Other Gross PP&E Adjustments fell 40.51% year-over-year to $44.5 million; the TTM figure through Mar 2026 stood at $44.5 million (down 40.51% YoY), while the FY2025 annual figure was $41.6 million, down 42.58% from the prior year.
  • Other Gross PP&E Adjustments came in at $44.5 million for Q1 2026 at Sana Biotechnology, up from $41.6 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $74.9 million in Q1 2025 to a low of -$8.0 million in Q1 2022.
  • A 5-year average of $34.6 million and a median of $41.1 million in 2025 frame the typical range for Other Gross PP&E Adjustments.
  • Across the five-year window, Other Gross PP&E Adjustments tumbled 181.06% in 2022 and soared 7223.56% in 2023, its largest moves.
  • Sana Biotechnology's Other Gross PP&E Adjustments stood at $7.2 million in 2022, then surged by 397.75% to $36.1 million in 2023, then jumped by 100.96% to $72.5 million in 2024, then sank by 42.58% to $41.6 million in 2025, then rose by 6.95% to $44.5 million in 2026.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $44.5 million, $41.6 million, and $41.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Sana Biotechnology 890.09 Mn 890.09 Mn - 44.54 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 44.54 Mn
Mar 31, 2026 44.54 Mn
Dec 31, 2025 41.64 Mn
Dec 31, 2025 41.64 Mn
Sep 30, 2025 41.12 Mn
Sep 30, 2025 41.12 Mn
Jun 30, 2025 41.22 Mn
Jun 30, 2025 41.22 Mn
Mar 31, 2025 74.87 Mn
Mar 31, 2025 74.87 Mn
Dec 31, 2024 72.52 Mn
Dec 31, 2024 72.52 Mn
Sep 30, 2024 73.00 Mn
Sep 30, 2024 73.00 Mn
Jun 30, 2024 69.64 Mn
Jun 30, 2024 69.64 Mn
Mar 31, 2024 52.09 Mn
Mar 31, 2024 52.09 Mn
Dec 31, 2023 36.09 Mn
Dec 31, 2023 36.09 Mn
Sep 30, 2023 35.97 Mn
Sep 30, 2023 35.97 Mn
Jun 30, 2023 8.95 Mn
Jun 30, 2023 8.95 Mn
Mar 31, 2023 3.66 Mn
Mar 31, 2023 3.66 Mn
Dec 31, 2022 7.25 Mn
Dec 31, 2022 7.25 Mn
Sep 30, 2022 -505,000.00
Sep 30, 2022 -505,000.00
Jun 30, 2022 -6.46 Mn
Jun 30, 2022 -6.46 Mn
Mar 31, 2022 -8.01 Mn
Mar 31, 2022 -8.01 Mn
Dec 31, 2021 -14.05 Mn
Dec 31, 2021 -14.05 Mn
Sep 30, 2021 -8.12 Mn
Sep 30, 2021 -8.12 Mn
Jun 30, 2021 8.06 Mn
Jun 30, 2021 8.06 Mn
Mar 31, 2021 -2.85 Mn
Mar 31, 2021 -2.85 Mn
Dec 31, 2020 -10.37 Mn
Dec 31, 2020 -10.37 Mn